Back
Viking Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
VKTX
Viking Therapeutics
Last Price:
$22.21
Seasonality Move:
11.55%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.79 | Sell |
| 20-day SMA: | 25.97 | Sell |
| 50-day SMA: | 28.61 | Sell |
| 200-day SMA: | 48.58 | Sell |
| 8-day EMA: | 22.81 | Sell |
| 20-day EMA: | 25.03 | Sell |
| 50-day EMA: | 29.28 | Sell |
| 200-day EMA: | 42.09 | Sell |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.22 | Sell |
| Relative Strength Index (14 RSI): | 37.11 | Sell |
| Chaikin Money Flow: | 302604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.4 - 29.64) | Sell |
| Bollinger Bands (100): | (26.85 - 46.55) | Sell |
Viking Therapeutics Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 21.52 while VKTX 8-day simple moving average is 22.79, which is a Sell signal.
-
The stock price of VKTX is 21.52 while Viking Therapeutics 20-day SMA is 25.97, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 28.61 while VKTX share price is 21.52, making it a Sell technically.
-
VKTX stock price is 21.52 and Viking Therapeutics 200-day simple moving average is 48.58, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
27
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $21.52. The Score for VKTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
21.52
Share Volume:
4.5M
Viking Therapeutics 52-Week Range
52-Week High:
81.86
52-Week Low:
18.92
Sell
27
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 21.52 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 21.52 while VKTX 8-day exponential moving average is 22.81, which is a Sell signal.
-
The stock price of VKTX is 21.52 while Viking Therapeutics 20-day EMA is 25.03, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 29.28 while VKTX share price is 21.52, making it a Sell technically.
-
VKTX stock price is 21.52 and Viking Therapeutics 200-day simple moving average is 42.09, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.54 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -2.22, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 37.11, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (23.4 - 29.64), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (26.85 - 46.55), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.